Form 4: Aveanna Healthcare Holdings Insider Robert M. Williams Jr. Reports Stock Sales

Robert M. Williams Jr., a director at Aveanna Healthcare Holdings, reported the sale of common stock through a pre-arranged Rule 10b5-1 trading plan.

Summary

• Robert M. Williams Jr., a director at Aveanna Healthcare Holdings, Inc., filed a Form 4 detailing transactions in the company's common stock.
• The transactions involved sales of common stock executed on March 24 and March 25, 2025, at weighted average prices of $5.63 and $5.64, respectively.
• These sales were conducted automatically under a pre-existing Rule 10b5-1 trading plan adopted on December 13, 2024, by J.H. Whitney VII, L.P. and other stockholder entities.
• The sales resulted in a decrease in the number of shares indirectly beneficially owned by Williams through various entities, including J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, PSA Iliad Holdings LLC, and JHW Iliad Holdings II LLC.
• Williams disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
• Williams has authorized Paul R. Vigano and David Zatlukal to execute and file Forms 3, 4, and 5 on his behalf with the SEC.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document is a standard regulatory filing reporting stock sales under a pre-arranged trading plan. There is no indication of positive or negative sentiment towards the company's prospects.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common in publicly traded companies. It provides transparency into the actions of company insiders and their potential views on the company's stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, as mandated by the SEC.
• The use of Rule 10b5-1 trading plans is a common method for insiders to sell shares without being accused of trading on non-public information.
• Comparable companies in the healthcare sector also have similar insider trading disclosures.

Stakeholder Impact

• The stock sales may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price.
• The impact on other stakeholders (employees, customers, suppliers, creditors) is likely to be minimal.

Key Dates

Keywords

Form 4, insider trading, stock sales, Aveanna Healthcare Holdings, AVAH, Robert M. Williams Jr., Rule 10b5-1, J.H. Whitney VII, PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, PSA Iliad Holdings LLC, JHW Iliad Holdings II LLC